US FDA approves emergency use of remdesivir for COVID-19 patients
Washington: The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the experimental anti-viral drug remdesivir to treat COVID-19.
In an FDA fact sheet for patients and their families and caregivers, the…
Read More...
Read More...